Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.

Mi Hyeon YouMin Ji JeonTae Yong KimWon Bae KimYoung Kee ShongWon Gu Kim

Published in: Endocrinology and metabolism (Seoul, Korea) (2020)

Our study suggests that NF2 might play a role as a tumor suppressor in thyroid cancer with BRAF mutation. More studies are needed to elucidate the mechanism how NF2 acts in thyroid cancer with BRAF mutation.

Keyphrases

signaling pathway
lps induced
pi k akt
nuclear factor
oxidative stress
wild type
poor prognosis
inflammatory response
metastatic colorectal cancer
cell proliferation
immune response
case control